Supporting the rapid development and approval of effective and safe treatments for and vaccines against COVID-19 is EMA’s top priority…
In the last few months, Artificial Intelligence started to become a big thing within many areas, e.g. the creative industry.…
Overview Atripla is an antiviral medicine used to treat adults infected with human immunodeficiency virus-1 (HIV-1), a virus that causes…
Tegsedi addresses unmet medical need for treatment of hereditary transthyretin amyloidosis The European Medicines Agency’s (EMA) Committee for Medicinal Products…
EMA’s safety committee (PRAC) has confirmed its recommendation to limit the use of high-strength creams containing 100 micrograms/gram (0.01%) of…
EMA has concluded that omega-3 fatty acid medicines are not effective in preventing further heart and blood vessels problems in…
Table of contents What’s new Supporting the development of medicines and vaccines Advice on clinical trials Monitoring the impact on…
During an extraordinary virtual meeting held on 2 April 2020, EMA’s human medicines committee (CHMP) gave recommendations on how the…
PRAC starts review of certain ifosfamide cancer medicines At its monthly meeting, EMA’s safety committee (PRAC) has started a review…